CN Patent

CN103260603B — 用于治疗关节痛的皮质类固醇

Assigned to Pacira Therapeutics Inc · Expires 2017-11-10 · 9y expired

What this patent protects

提供了皮质类固醇微粒制剂以用于治疗疼痛，包括由炎性疾病诸如骨关节炎或类风湿性关节炎所引起的疼痛在内，以及用于减缓、阻止或逆转由炎性疾病所引起的组织结构损伤，例如由骨关节炎或类风湿性关节炎所引起的关节和/或关节周围组织损伤。以缓释剂型（含有或不含立即释放组分）局部给药皮质类固醇微粒制剂，该缓释剂型在产生效力的同时对内源性皮质醇生产具有临床上非显著性的影响或者不具有可测量的影响。

USPTO Abstract

提供了皮质类固醇微粒制剂以用于治疗疼痛，包括由炎性疾病诸如骨关节炎或类风湿性关节炎所引起的疼痛在内，以及用于减缓、阻止或逆转由炎性疾病所引起的组织结构损伤，例如由骨关节炎或类风湿性关节炎所引起的关节和/或关节周围组织损伤。以缓释剂型（含有或不含立即释放组分）局部给药皮质类固醇微粒制剂，该缓释剂型在产生效力的同时对内源性皮质醇生产具有临床上非显著性的影响或者不具有可测量的影响。

Drugs covered by this patent

Patent Metadata

Patent number
CN103260603B
Jurisdiction
CN
Classification
—
Expires
2017-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Pacira Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.